Literature DB >> 24357578

Longitudinal assessment of cognition and T2-hyperintensities in NF1: an 18-year study.

Jonathan M Payne1, Tania Pickering, Melanie Porter, Emily C Oates, Navdeep Walia, Kristina Prelog, Kathryn N North.   

Abstract

The developmental course of cognitive deficits in individuals with neurofibromatosis type 1 (NF1) is unclear. The objectives of this study were to determine the natural history of cognitive function and MRI T2-hyperintesities (T2H) from childhood to adulthood and to examine whether the presence of discrete T2H in childhood can predict cognitive performance in adulthood. We present cognitive and structural neuroimaging data from 18 patients with NF1 and five sibling controls assessed prospectively across an 18-year period. Longitudinal analyses revealed a significant increase in general cognitive function in patients with NF1 over the study period. Improvements were limited to individuals with discrete T2H in childhood. Patients without lesions in childhood exhibited a stable profile. The number of T2H decreased over time, particularly discrete lesions. Lesions located within the cerebral hemispheres and deep white matter were primarily stable, whereas those located in the basal ganglia, thalamus and brainstem tended to resolve. Our results support the hypothesis that resolution of T2H is accompanied by an improvement in general cognitive performance, possibly as a result of increased efficiency within white matter tracts.
© 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  cognition; longitudinal studies; magnetic resonance imaging; neurofibromatosis type 1

Mesh:

Year:  2013        PMID: 24357578     DOI: 10.1002/ajmg.a.36338

Source DB:  PubMed          Journal:  Am J Med Genet A        ISSN: 1552-4825            Impact factor:   2.802


  18 in total

1.  Cerebellar Hypoplasia and Dysmorphia in Neurofibromatosis Type 1.

Authors:  Sandra P Toelle; Andrea Poretti; Peter Weber; Tatjana Seute; Jacoline E C Bromberg; Ianina Scheer; Eugen Boltshauser
Journal:  Cerebellum       Date:  2015-12       Impact factor: 3.847

2.  Perfusion single photon emission computed tomography in a mouse model of neurofibromatosis type 1: towards a biomarker of neurologic deficits.

Authors:  Ivayla Apostolova; Dagmara Niedzielska; Thorsten Derlin; Eva J Koziolek; Holger Amthauer; Benedikt Salmen; Jens Pahnke; Winfried Brenner; Victor F Mautner; Ralph Buchert
Journal:  J Cereb Blood Flow Metab       Date:  2015-03-18       Impact factor: 6.200

3.  Spontaneously regressing brain lesions in Smith-Lemli-Opitz syndrome.

Authors:  An N Dang Do; Eva H Baker; Katherine E Warren; Simona E Bianconi; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2017-12-11       Impact factor: 2.802

4.  Parent-Reported Social Skills in Children with Neurofibromatosis Type 1: Longitudinal Patterns and Relations with Attention and Cognitive Functioning.

Authors:  Danielle M Glad; Christina L Casnar; Brianna D Yund; Kristin Lee; Bonita P Klein-Tasman
Journal:  J Dev Behav Pediatr       Date:  2021 Oct-Nov 01       Impact factor: 2.225

5.  Focal Areas of High Signal Intensity in Children with Neurofibromatosis Type 1: Expected Evolution on MRI.

Authors:  S Calvez; R Levy; R Calvez; C-J Roux; D Grévent; Y Purcell; K Beccaria; T Blauwblomme; J Grill; C Dufour; F Bourdeaut; F Doz; M P Robert; N Boddaert; V Dangouloff-Ros
Journal:  AJNR Am J Neuroradiol       Date:  2020-08-13       Impact factor: 3.825

6.  A role for sustained MAPK activity in the mouse ventral telencephalon.

Authors:  Mary Jo Talley; Diana Nardini; Shenyue Qin; Carlos E Prada; Lisa A Ehrman; Ronald R Waclaw
Journal:  Dev Biol       Date:  2021-03-26       Impact factor: 3.148

7.  Predictors of cognitive development in children with neurofibromatosis type 1 and plexiform neurofibromas.

Authors:  Yang Hou; Taryn Allen; Pamela L Wolters; Mary Anne Toledo-Tamula; Staci Martin; Andrea Baldwin; Stephanie Reda; Andy Gillespie; Anne Goodwin; Brigitte C Widemann
Journal:  Dev Med Child Neurol       Date:  2020-02-12       Impact factor: 4.864

8.  Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.

Authors:  Edward Kim; Yuan Wang; Sun-Jung Kim; Miriam Bornhorst; Emmanuelle S Jecrois; Todd E Anthony; Chenran Wang; Yi E Li; Jun-Lin Guan; Geoffrey G Murphy; Yuan Zhu
Journal:  Elife       Date:  2014-12-23       Impact factor: 8.140

Review 9.  Cognitive and Behavioral Disorders in Children with Neurofibromatosis Type 1.

Authors:  Martha Milade Torres Nupan; Alberto Velez Van Meerbeke; Claudia Alejandra López Cabra; Paula Marcela Herrera Gomez
Journal:  Front Pediatr       Date:  2017-10-30       Impact factor: 3.418

Review 10.  Attention deficit hyperactivity disorder (ADHD) in phenotypically similar neurogenetic conditions: Turner syndrome and the RASopathies.

Authors:  Tamar Green; Paige E Naylor; William Davies
Journal:  J Neurodev Disord       Date:  2017-07-10       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.